Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.17
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
15.22
0.33%
After-hours: Aug 15, 2025, 06:46 PM EDT
Immunovant Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 160K | 160K | 1.5M | 1.5M | 1.5M | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 925.8K | 925.8K | 925.8K |
Cost of Revenue | 375K | 348K | 332K | 291K | 551K | 814K | 1.09M | 1.37M | 1.34M | 1.32M | 1.3M | 1.28M | 1.25M | 1.23M | 1.16M | 846K | 541K | 241K | 462.9K | 462.9K | 858.06K |
Gross Profit | -215K | -188K | 1.17M | 1.21M | 949K | 686K | -1.09M | -1.37M | -1.34M | -1.32M | -1.3M | -1.28M | -1.25M | -1.23M | -1.16M | -846K | -541K | -241K | 462.9K | 462.9K | 67.74K |
Operating Income | -471.1M | -438.15M | -405.2M | -342.43M | -284.89M | -264.56M | -248M | -240.5M | -231.9M | -198.33M | -181.28M | -178.64M | -166.68M | -156.19M | -137.84M | -128.09M | -111.42M | -108.12M | -99.68M | -79.08M | -58.53M |
Interest Income | 23.89M | 24.73M | 26.22M | 30.57M | 28.06M | 24.95M | 20.05M | 14.06M | 11.64M | 7.58M | 4.1M | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 683.14K |
Pretax Income | -445.58M | -412.95M | -382.17M | -322.73M | -271.89M | -258.77M | -244.1M | -255.42M | -244.88M | -210.95M | -197.71M | -176.26M | -166.32M | -156.81M | -137.87M | -128.63M | -111.64M | -107.79M | -100.16M | -79.22M | -58.2M |
Net Income | -447.3M | -413.84M | -382.71M | -323.01M | -272.55M | -259.34M | -243.45M | -255.26M | -244.52M | -210.96M | -198.7M | -176.86M | -166.63M | -156.73M | -137.72M | -128.11M | -111.19M | -107.43M | -99.82M | -79.34M | -58.43M |
Selling & General & Admin | 84.53M | 77.23M | 71.74M | 65.17M | 60.54M | 57.22M | 54.88M | 53.44M | 51.47M | 48.02M | 50.84M | 50.58M | 54.99M | 54.23M | 49.29M | 48.32M | 41.03M | 39.51M | 35.53M | 31.07M | 26.23M |
Research & Development | 386.64M | 360.92M | 333.32M | 287.14M | 237.83M | 212.93M | 198.71M | 192.62M | 182.4M | 160.26M | 140.41M | 127.91M | 111.53M | 101.81M | 88.44M | 79.77M | 70.39M | 68.6M | 64.16M | 48.02M | 46.37M |
Other Expenses | n/a | 28K | 28K | 28K | 48K | 484K | 840K | 840K | 820K | 710K | 398K | 284K | 200K | -154K | -198K | -84K | n/a | -74K | -201K | -201K | 218.76K |
Operating Expenses | 471.18M | 438.15M | 405.06M | 352.31M | 298.37M | 270.14M | 253.59M | 246.06M | 233.88M | 208.28M | 191.24M | 178.49M | 166.52M | 156.03M | 137.72M | 128.09M | 111.42M | 108.12M | 99.68M | 79.08M | 58.53M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 249K | 625K | 625K |
Selling & Marketing Expenses | 80K | 80K | -64K | -64K | -64K | -64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 471.25M | 438.31M | 405.2M | 352.46M | 298.51M | 270.21M | 253.59M | 246.06M | 233.88M | 208.28M | 191.24M | 178.49M | 166.52M | 156.03M | 137.72M | 128.09M | 111.42M | 108.12M | 99.68M | 79.08M | 58.53M |
Income Tax Expense | 1.73M | 891K | 539K | 279K | 655K | 567K | -657K | -162K | -355K | 8K | 988K | 321K | 29K | -364K | -431K | -518K | -447K | -358K | -338K | 129K | 227.29K |
Shares Outstanding (Basic) | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M | 129.63M | 128.57M | 116.57M | 116.56M | 116.34M | 115.03M | 109.08M | 97.98M | 97.79M | 97.92M | 97.92M | 84.35M |
Shares Outstanding (Diluted) | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M | 129.63M | 128.57M | 116.57M | 116.56M | 116.34M | 115.03M | 109.08M | 97.98M | 97.97M | 97.92M | 97.92M | 84.35M |
EPS (Basic) | -2.85 | -2.74 | -2.62 | -2.22 | -1.93 | -1.9 | -1.84 | -1.97 | -1.93 | -1.71 | -1.66 | -1.53 | -1.47 | -1.43 | -1.31 | -1.27 | -1.13 | -1.14 | -1.14 | -1.1 | -0.85 |
EPS (Diluted) | -2.85 | -2.74 | -2.62 | -2.22 | -1.93 | -1.9 | -1.84 | -1.97 | -1.93 | -1.71 | -1.66 | -1.53 | -1.47 | -1.43 | -1.31 | -1.27 | -1.13 | -1.14 | -1.14 | -1.1 | -0.88 |
EBITDA | -437.96M | -412.57M | -404.87M | -352.17M | -298.25M | -269.98M | -253.37M | -245.85M | -233.68M | -208.08M | -191.06M | -178.32M | -166.19M | -155.72M | -136.81M | -127.19M | -110.72M | -107.44M | -99.76M | -78.96M | -58.42M |
EBIT | -438.37M | -412.95M | -405.2M | -352.46M | -298.51M | -270.21M | -253.59M | -246.06M | -233.88M | -208.28M | -191.24M | -178.49M | -166.52M | -156.03M | -137.04M | -127.41M | -110.74M | -107.44M | -99.81M | -78.99M | -58.44M |
Depreciation & Amortization | 404K | 377K | 332K | 291K | 258K | 521K | 798K | 1.07M | 1.34M | 1.32M | 1.3M | 1.28M | 1.25M | 1.23M | 1.16M | 865K | 574K | 284K | 49K | 35K | 26K |